Clinical Efficiencies
October 19, 2010
Mike Lange, a senior manager at ClearTrial, is not a board-certified oncologist. But he is breezing through a demonstration of the Chicago company’s software. There is a faux oncology trial on Lange’s screen, and he sets himself the task of finishing a few months early. The software produces rapid, highly detailed clinical trial budgets and time lines.…more...
Clinical Efficiencies
October 12, 2010
There are people who feel clinical trials are artistic endeavors. That the same practices which drive efficiency in other industries cannot be applied to clinical development, any more than efficiency is germane to making a sketch or a symphony. Barry Templin is emphatically not one of those people.
Associate director of clinical programs at Abbott Vascular, Templin…more...
Biotech Focus
August 10, 2009
The biotechnology sector may be stumbling. Even so, Synteract, a medium/small contract research organization (CRO) that works almost exclusively with biotechs, is doing fine.
No, 2009 won't be 2008, when the company experienced 35 percent growth. But 2009 won't be terrible, either. Synteract CEO, president and co-founder Ellen Morgan projects 8 percent growth. “Hopefully, if things improve…more...
New Network for Spine Studies
May 05, 2008
Research on the spine is where cardiac research was 10 years ago, declares Marcy Rogers. And that’s why she’s working hard to establish a presence in what she considers a soon-to-boom field.
Enter, then, San Diego-based SpineMark CRO Management, the industry’s sole spine-only contract research organization (CRO), launched in 2005 but recently ramping up considerably. Rogers is…more...
Friday News Briefs
DataTrak Revenues Fall
Bulletins about etrials, KGK Synergize, Take Solutions, Huntingdon, PostPath, Qumas and P&G.
Litigation Protection
Clinical Trial Insurance
It may not be illegal to go without a policy in the U.S., but venture capitalists and clinical sites won’t work with sponsors who don’t have clinical trial insurance.
Making Ends Meet
Bridge Loans for Clinical Sites
Thanks to the 140-day delay in payments from sponsors, many pinched clinical sites find themselves in need of a loan. One company out there that understands trials is there to give it to them—for a fee.
Quick Turnaround
Covance On Microdosing
Covance just completed its fourth microdosing trial, and execs with the big CRO think the approach is promising.
Low Interest So Far
Microdosing Update From FDA
Yes, microdosing is part of the FDA’s Critical Path Initiative. But no, sponsors don’t seem to be interested in extremely low-dose trials yet. Why? The FDA’s David Jacobson-Kram offers some thoughts.
Acquisition Factor
Kendle Posts $4.7M Loss
The big picture at the major contract research organization (CRO) remains rosy, with quarterly revenue jumping 78 percent.
4 CROs pick company
etrials Wins 10 New Trials
Most of the new contracts include something besides electronic data capture (EDC): a clinical trial management system, an e-diary, or an interactive voice response system. Some customers are buying etrials’ technology and bringing everything in-house.
